Alts Logo SVG
Upgrade to paid

Inverse Cramer Weekly Update — Feb 4

Welcome to Inverse Cramer by ​Alts.co​: Tracking Jim Cramer’s stock picks so you can do the opposite 🙃

Monday, Jan 29

This got to be one of the most hated stocks ever. Every morning I came in and somebody would say cutting numbers and cutting prices. I’m going against them and say for $438, I’m finally ready to pull the trigger. At least a quarter of a position, it’s just too low.

-On Northrop Grumman (​$NOC​)

I’m fond of this company (Buy, Buy, Buy). It’s a little quirky but it’s good. Global industrial foods have always been my fave.

-On John Beam Tech (​$JBT​)

You’re not doing well at all. We don’t want AMC, it’s not doing well. We want stocks that go higher. Let’s understand that the consumers are not going the the movies like they used to. Why don’t you go buy Netflix?

-On AMC Entertainment (​$AMC​)

Tuesday, Jan 30

That industry is in up and down, up and down, right now. It is too hard for this guy. I’m taking a hard pass.

-On Surgery Partners (​$SGRY​)

It is still not too late to buy Energy Transfer (Buy, Buy, Buy).

-On Energy Transfer (​$ET​)

I haven’t liked Vodafone for 20 years, and it’s rewarded my dislike. I’m gonna say something monumental right here right now, I am willing to recommend the stock of Verizon.

-On Vodafone (​$VOD​)

I like those guys, but I have no illusions. They’re losing a lot of money. We don’t like to recommend stocks that are losing money in Mad Money. If you recognize it as a spec, you can go for it, but I don’t recommend that stock on a mental basis.

-On Crispr Therapeutics (​$CRSP​)

Wednesday, Jan 31

It’s too low. I’ve been saying Sell, Sell, Sell. I’m now switching (Buy, Buy, Buy). Enough is enough, buy at $40.

-On Devon Energy (​$DVN​)

I think maybe it’s a spec, maybe it’s not well presented. I don’t know what’s going on. I do know it’s a good company but I like DraftKings more. I’m a DraftKings guy and it’s headed much higher.

-On SGHC (​$SGHC​)

It’s kind of a classic stock. It’s not sexy, it’s not that interesting, it’s a business that’s a good one. And it got what I call ‘horse sense’.

-On Simpson (​$SSD​)

Thursday, Feb 1

I think it’s fine. It’s very low, I think it’s something to look at.

-On Chewy (​$CHWY​)

These are airline stocks, and airline stocks should be making a lot of money. I’m not gonna start inventing reasons why we should own them, I just don’t have any.

-On JetBlue Airways (​$JBLU​)

I like Home Depot. It’s got a very good run. It also has a very good yield.

-On Home Depot (​$HD​)

Friday, Feb 2

I think you’re right about Block. Jack is back doing his thing. Block or Square is going higher, and you’ve got a winner.

-On Block (​$SQ​)

We now feel to wait another quarter to see what they will gonna do. We don’t wanna jump too soon. This is a troubled situation.

-On Walgreen Boots (​$WBA​)

What a quarter they put. They’re just killing it. I saw what Shugar did, WOW, what a monster quarter. It sells 20x its earnings. Could it go higher? Perhaps, but it’s a good company. Kind of caught me a bit by surprise.

-On Nextracker (​$NXT​)

Cramer Classic

Weekend Bonus

That’s a wrap. As always, we’ll be following Cramer’s every move so you can do the opposite.

Enjoy the week ahead.

-IC

Disclosures

  • This issue was sponsored by our friends at First National Realty Partners
  • Neither the author nor the ALTS 1 Fund has no holdings in any companies mentioned in this issue
  • This issue contains affiliate links to TradingView. If you sign up we get a few bucks.

Share

Author

Inverse Cramer

Inverse Cramer

Related Posts

chickens graphic

Let’s buy chickens

The American Consumer Can’t Prop up the Economy Anymore, What’s Next for Collectable Shareholders. The Global Collapse No One Is Talking About, and More.

May 1, 2024
staglfation

Stagflation: Tipping Point or Tempest in a Teapot

GDP grew at its slowest rate since Q2 2022, Homes had a median of 50 days on the market, Xaira Therapeutics unveiled $1 billion in funding, Goldman hired two bankers from JPMorgan, and More.

April 29, 2024
jim cramer

Inverse Cramer Weekly Update — Apr 29

Yeah it has ups and downs. That’s why if you want an insurance business, I’m gonna say Progressive. I think Progressive is better -On Travelers (​$TRV​)

April 29, 2024
smuckers

China invades Mexico

Hollywood Embraces AI Cloning for A-List Talent, The Billion-Dollar Crustless Sandwich Empire, Chinese Manufacturers Flock to Mexico, and More.

April 26, 2024
Alts1 Fund Graphic Small

Recently Published

Unique investment ideas worth exploring

Our newsletter is everything. Start here.

    Join thousands of subscribers.
    Absolutely spam-free.

    Website
    Address
    651 North Broad Street, Suite 206 Middletown, DE 19709
    Subscribe to Newsletter
    Alternative Assets - Unique investment ideas worth exploring | Product Hunt
    Linkedin Youtube Instagram Podcast Tiktok Twitter
    © 2023 Alt Assets, Inc. All Rights Reserved

    Disclaimer: The authors of Alt Assets, Inc. are not finance or tax professionals. They are self-taught accredited investors, sharing information, research, and lessons learned. The published content is unique, based on certain assumptions and market conditions at the time of publishing and is intended to serve solely as research, not financial advice. Alts I LLC (the “Fund”) is an affiliate of Alt Assets, Inc. and the Fund has conducted a private placement offering under Rule 506(c) of Regulation D of the Securities Act of 1933, as amended. The Fund may invest in one, several or all of the alternative asset classes that Alt Assets, Inc. publishes content on its site. Any published articles on Alt Assets, Inc. that an alternative asset has a “buy”, “pass”, “overvalued” or “undervalued” designation does not factor into the asset classes that the Fund through its manager ultimately invests in, and thus, any of the Fund’s investments that have positive designations on the Alt Assets, Inc.’s site are purely coincidental as the Fund is actively managed and guided by its own investment parameters as summarized in the relevant private placement memorandum.